About the Conference

Building on the success of our program in 2005, Nixon Peabody LLP and Genomic Healthcare Strategies are pleased to announce “Personalized Medicine: Breaking Down the Barriers and Achieving Results,” a full day program that will address the many facets of personalized medicine and the obstacles that need to be overcome to bring products to market.

Personalized medicine will redefine all aspects of health care delivery: for the companies that provide the innovations; for the way patients view their health, their disease, and the quality of the care they receive; and for the traditional systems that govern and pay for life sciences and health care. Many of the traditional relationships among health care innovators, providers, and consumers are about to change dramatically. Biotech, pharma, and investors will face new models of practice and payments in this changed landscape. Patients, physicians, and payors will have rapidly evolving, competing ideas of what constitutes good health care.

Bringing personalized medicine products to market in this evolving landscape presents a unique set of challenges. The leaders in molecular medicine will be those who have prepared strategies that enable them to anticipate, incorporate, and take advantage of the changes that grow out of this revolution in health care.

We look forward to your participation in this exciting program. Please sign up early as space is limited.